Psomagen, Inc. is adapting to the public’s changing COVID-19 testing needs by expanding its SARS-CoV-2 diagnostic services. In addition to its GutBiome and Gene Trait testing, the company now offers direct-to-consumer saliva collection kits for diagnosing COVID-19 for adults age 18 and older. Individuals tested must submit a qualification questionnaire and receive authorization through a national physician network service included with the kit. Unlike other testing options, this service does not require individuals to leave their home, better protecting their safety and the public’s. Saliva samples shipped to Psomagen’s US-based service lab are used in the SalivaDirect™ protocol, an innovative and cost-effective saliva-based COVID-19 test developed by Yale School of Public Health (YSPH). This RT-PCR method detects both symptomatic and asymptomatic coronavirus infections. Psomagen offers two other EUA-authorized SARS-CoV-2 tests including the saliva-based SalivaDirect diagnostic test and the swab-based Psoma COVID-19 RT Coronavirus Test. Both tests are available to order for business-use through Psomagen. Individual customers can purchase an at-home SalivaDirect kit and other health-related screening tests through MyPsomagen.com.